Cancer Diagnostics Market Examined In New Market Research Report

Cancer Diagnostics Market Examined In New Market Research Report

Credence Research, the leading business intelligence provider, has published its latest research, “Cancer Diagnostics Market 2026″, which gives insights into Cancer Diagnostics in the Global market. The report determines the market size for 2018, along with forecasts until 2026. It is built using data and information sourced from exclusive databases, primary and secondary research, and in-house analysis carried out by Credence Research’s team of industry experts.

Browse Here For Full Report:

Market Insights:

Cancer diagnostics pave the way to understand the disease progression and the ways in which therapeutic treatment counteract the disease. Discovery of novel cancer diagnostic techniques are expanding at an unmatched rate due to investments in molecular biology and genomic sciences. Burgeoning prevalence of cancer across the globe expected to facilitate rise in demand for cancer diagnostics market during the forecast period. Cancer claims one in six life globally, accounting for more deaths than tuberculosis, AIDS and malaria combined.

According to International Agency of Research on Cancer (IARC), there were 14.8 million new cases of cancer and 8.8 million cancer deaths in 2015 worldwide.

This number is projected to grow to 21.7 million new cases and 13 million deaths due to cancer by 2030 owing to growing geriatric population. Growing awareness regarding the early diagnosis of cancer in developed and developing countries is the prime factor for the growth of cancer diagnostics market.

Download Free Request Sample:

This awareness is supported by favourable government initiatives to promote cancer testing, heightened research & development in the field of oncology and easy availability of point-of-care diagnostic kits are further driving the cancer diagnostics market. Number of biopharmaceutical companies are coming up with novel diagnostic technique that are highly accurate and pocket friendly. Number of health conscious people in the developed countries are opting for cancer tests for early traits and possibilities of oncogenic mutations to take prior steps in cancer prevention. These factors will assist the growth of cancer diagnostics market during the forecast period from 2018 to 2026.

Leading Players:

The prominent players operating the global cancer diagnostics market are Abbott Laboratories, Qiagen, F. Hoffman-La Roche, Alere, Inc., GE Healthcare, Siemens Healthineers, Agilent Technologies, among others.


  • The report presents the brief overview of Cancer Diagnostics Market including business description, key information and facts, and its locations and subsidiaries
  • The report features product description and descriptive mechanism of action for key products along with the products developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued projects
  • Latest company statement
  • Latest news and deals relating to the Cancer Diagnostics products

Browse Here For Full Report:

Research methodology

The following research methods were used in this report:

  • Desk study
  • A questionnaire survey among specialty retail chains
  • Analyzing statistical data released by the Federal Customs Service
  • Desk study sources include materials taken from print and online media conference materials.

Reasons to Buy

  • The report provides information about technology solutions needed for the implementation of Cancer Diagnostics projects, and allows readers to make effective business decisions
  • The report helps readers to strengthen strategic framework by understanding the business benefits to be achieved through Cancer Diagnostics solutions
  • The report highlights projected investment on Cancer Diagnostics over the next two years. This will help organizations to allocate budget towards Cancer Diagnostics implementation and business expansion
  • The report helps executives plan their adoption of Cancer Diagnostics by providing expected timeframes for implementation

Get Request For Customization

Briefing wire:

About Us

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290



LinkedIn @

Facebook Comments

Share this post